Fintel reports that on May 20, 2026, Maxim Group upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Hold to Buy.
Analyst Price Forecast Suggests 23.89% Upside
As of May 15, 2026, the average one-year price target for Gilead Sciences is $161.68/share. The forecasts range from a low of $123.22 to a high of $189.00. The average price target represents an increase of 23.89% from its latest reported closing price of $130.50 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Gilead Sciences is 28,098MM, a decrease of 5.51%. The projected annual non-GAAP EPS is 7.27.
What is the Fund Sentiment?
There are 2,350 funds or institutions reporting positions in Gilead Sciences. This is an decrease of 853 owner(s) or 26.63% in the last quarter. Average portfolio weight of all funds dedicated to GILD is 0.24%, an increase of 40.65%. Total shares owned by institutions decreased in the last three months by 4.93% to 1,201,600K shares. 
The put/call ratio of GILD is 0.57, indicating a bullish outlook.
What are Other Shareholders Doing?
Vanguard Capital Management holds 80,655K shares representing 6.50% ownership of the company.
Capital World Investors holds 41,284K shares representing 3.33% ownership of the company. In its prior filing, the firm reported owning 42,872K shares , representing a decrease of 3.85%. The firm increased its portfolio allocation in GILD by 9.68% over the last quarter.
Vanguard Portfolio Management holds 35,129K shares representing 2.83% ownership of the company.
Jpmorgan Chase holds 33,992K shares representing 2.74% ownership of the company. In its prior filing, the firm reported owning 23,036K shares , representing an increase of 32.23%. The firm decreased its portfolio allocation in GILD by 81.86% over the last quarter.
Geode Capital Management holds 29,726K shares representing 2.39% ownership of the company. In its prior filing, the firm reported owning 29,696K shares , representing an increase of 0.10%. The firm decreased its portfolio allocation in GILD by 38.76% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
